标题
Targeting of proangiogenic signalling pathways in chronic inflammation
作者
关键词
-
出版物
Nature Reviews Rheumatology
Volume 12, Issue 2, Pages 111-122
出版商
Springer Nature
发表日期
2015-12-03
DOI
10.1038/nrrheum.2015.164
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The clinically approved drugs dasatinib and bosutinib induce anti-inflammatory macrophages by inhibiting the salt-inducible kinases
- (2015) James Ozanne et al. BIOCHEMICAL JOURNAL
- Phase II study of pazopanib as second-line treatment after sunitinib in patients with metastatic renal cell carcinoma: A Southern China Urology Cancer Consortium Trial
- (2015) Mian Xie et al. EUROPEAN JOURNAL OF CANCER
- A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia
- (2015) Ivan Diaz-Padilla et al. GYNECOLOGIC ONCOLOGY
- Phase II study of the PI3K inhibitor pilaralisib (SAR245408; XL147) in patients with advanced or recurrent endometrial carcinoma
- (2015) Ursula Matulonis et al. GYNECOLOGIC ONCOLOGY
- Non-canonical NF-κB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde?
- (2015) Ae R Noort et al. ARTHRITIS RESEARCH & THERAPY
- Sphingosine-1-phosphate receptor 3 promotes leukocyte rolling by mobilizing endothelial P-selectin
- (2015) Claudia Nussbaum et al. Nature Communications
- Evaluation of synovial angiogenesis in patients with rheumatoid arthritis using68Ga-PRGD2 PET/CT: a prospective proof-of-concept cohort study
- (2014) Zhaohui Zhu et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate
- (2014) Edward C Keystone et al. ANNALS OF THE RHEUMATIC DISEASES
- PP242 suppresses cell proliferation, metastasis, and angiogenesis of gastric cancer through inhibition of the PI3K/AKT/mTOR pathway
- (2014) Xiaofang Xing et al. ANTI-CANCER DRUGS
- Ginsenoside compound K inhibits angiogenesis via regulation of sphingosine kinase-1 in human umbilical vein endothelial cells
- (2014) Kyong-Oh Shin et al. ARCHIVES OF PHARMACAL RESEARCH
- Inhibitors of angiogenesis: Ready for prime time?
- (2014) Chrissta X. Maracle et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- A FAK scaffold inhibitor disrupts FAK and VEGFR-3 signaling and blocks melanoma growth by targeting both tumor and endothelial cells
- (2014) Elena Kurenova et al. CELL CYCLE
- Targeting FAK in human cancer: from finding to first clinical trials
- (2014) Vita Golubovskaya Frontiers in Bioscience-Landmark
- A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma
- (2014) Ana De Jesus-Acosta et al. INVESTIGATIONAL NEW DRUGS
- Role of Sphingosine 1-Phosphate in the Pathogenesis of Sjogren's Syndrome
- (2014) M. Sekiguchi et al. JOURNAL OF IMMUNOLOGY
- Anti-Inflammatory Effects of Sphingosine Kinase Modulation in Inflammatory Arthritis
- (2014) W.-Q. Lai et al. JOURNAL OF IMMUNOLOGY
- NF-κB-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis
- (2014) Ae R Noort et al. JOURNAL OF PATHOLOGY
- IFNγ-responsiveness of endothelial cells leads to efficient angiostasis in tumours involving down-regulation of Dll4
- (2014) Jingjing Deng et al. JOURNAL OF PATHOLOGY
- Pericyte Dynamics during Angiogenesis: New Insights from New Identities
- (2014) Peter C. Stapor et al. JOURNAL OF VASCULAR RESEARCH
- Efficacy, safety, pharmacokinetics and pharmacodynamics of SAR245409 (voxtalisib, XL765), an orally administered phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor: a phase 1 expansion cohort in patients with relapsed or refractory lymphoma
- (2014) Kyriakos P. Papadopoulos et al. LEUKEMIA & LYMPHOMA
- A Multicenter Phase I Study of Pazopanib in Combination with Paclitaxel in First-Line Treatment of Patients with Advanced Solid Tumors
- (2014) K. L. Kendra et al. MOLECULAR CANCER THERAPEUTICS
- Oridonin Inhibits Tumor Growth and Metastasis through Anti-Angiogenesis by Blocking the Notch Signaling
- (2014) Yanmin Dong et al. PLoS One
- Pazopanib, a Receptor Tyrosine Kinase Inhibitor, Suppresses Tumor Growth through Angiogenesis in Dedifferentiated Liposarcoma Xenograft Models
- (2014) Haifu Li et al. Translational Oncology
- Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve-month data from a twenty-four-month phase III randomized radiographic study
- (2013) Désirée van der Heijde et al. ARTHRITIS AND RHEUMATISM
- Evidence That CXCL16 Is a Potent Mediator of Angiogenesis and Is Involved in Endothelial Progenitor Cell Chemotaxis: Studies in Mice With K/BxN Serum-Induced Arthritis
- (2013) Takeo Isozaki et al. ARTHRITIS AND RHEUMATISM
- Structure guided design of a series of sphingosine kinase (SphK) inhibitors
- (2013) Darin J. Gustin et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Small molecular compounds in development for rheumatoid arthritis
- (2013) Ronald F. van Vollenhoven CURRENT OPINION IN RHEUMATOLOGY
- A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors
- (2013) Ivan Diaz-Padilla et al. INVESTIGATIONAL NEW DRUGS
- A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575)
- (2013) Suzanne Richter et al. INVESTIGATIONAL NEW DRUGS
- LY2228820 Dimesylate, a Selective Inhibitor of p38 Mitogen-activated Protein Kinase, Reduces Angiogenic Endothelial Cord Formationin Vitroandin Vivo
- (2013) Courtney M. Tate et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial
- (2013) Gerd R Burmester et al. LANCET
- Therapeutic effects of sunitinib, one of the anti-angiogenetic drugs, in a murine arthritis
- (2013) Kazuhiro Furuya et al. Modern Rheumatology
- Notch inhibitors for cancer treatment
- (2013) Ingrid Espinoza et al. PHARMACOLOGY & THERAPEUTICS
- NF- B inhibitor targeted to activated endothelium demonstrates a critical role of endothelial NF- B in immune-mediated diseases
- (2013) B. Sehnert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Possible involvement of notch signaling in the pathogenesis of Buerger’s disease
- (2013) Hiroaki Tamai et al. SURGERY TODAY
- Macrophages and chemokines as mediators of angiogenesis
- (2013) Jennifer L. Owen et al. Frontiers in Physiology
- Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors
- (2012) B. Markman et al. ANNALS OF ONCOLOGY
- Notch signalling pathways mediate synovial angiogenesis in response to vascular endothelial growth factor and angiopoietin 2
- (2012) Wei Gao et al. ANNALS OF THE RHEUMATIC DISEASES
- Notch-1 mediates hypoxia-induced angiogenesis in rheumatoid arthritis
- (2012) Wei Gao et al. ARTHRITIS AND RHEUMATISM
- Pro-Angiogenic Activity of TLRs and NLRs: A Novel Link Between Gut Microbiota and Intestinal Angiogenesis
- (2012) Anja Schirbel et al. GASTROENTEROLOGY
- Celebrating 25 years of NF-κB research
- (2012) Sankar Ghosh et al. IMMUNOLOGICAL REVIEWS
- Sphingosine-1-phosphate modulates expression of vascular endothelial growth factor in human articular chondrocytes: a possible new role in arthritis
- (2012) Kayo Masuko et al. International Journal of Rheumatic Diseases
- Simultaneous targeting of TNF and Ang2 with a novel bispecific antibody enhances efficacy in an in vivo model of arthritis
- (2012) Palanisamy Kanakaraj et al. mAbs
- PI3 kinase/Akt/HIF-1α pathway is associated with hypoxia-induced epithelial–mesenchymal transition in fibroblast-like synoviocytes of rheumatoid arthritis
- (2012) Guo-Qing Li et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
- (2012) Roy Fleischmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
- (2012) Ronald F. van Vollenhoven et al. NEW ENGLAND JOURNAL OF MEDICINE
- MAP Kinase Pathways
- (2012) D. K. Morrison Cold Spring Harbor Perspectives in Biology
- Soluble VE-cadherin in rheumatoid arthritis patients correlates with disease activity: Evidence for tumor necrosis factor α-induced VE-cadherin cleavage
- (2011) Adama Sidibé et al. ARTHRITIS AND RHEUMATISM
- Angiogenesis in rheumatoid arthritis: A disease specific process or a common response to chronic inflammation?
- (2011) Alessandra Marrelli et al. AUTOIMMUNITY REVIEWS
- Antiangiogenic and Antimetastatic Activity of JAK Inhibitor AZD1480
- (2011) H. Xin et al. CANCER RESEARCH
- Nuclear factor-kappa B inhibitors; a patent review (2006 – 2010)
- (2011) Jae-Hwan Kwak et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Temporal Genome Expression Profile Analysis During T-cell-Mediated Colitis: Identification of Novel Targets and Pathways
- (2011) Kai Fang et al. INFLAMMATORY BOWEL DISEASES
- Tacrolimus (FK506) inhibits interleukin-1β-induced angiopoietin-1, Tie-2 receptor, and vascular endothelial growth factor through down-regulation of JNK and p38 pathway in human rheumatoid fibroblast-like synoviocytes
- (2011) Jung-Yoon Choe et al. JOINT BONE SPINE
- Phase I Trial of MK-0752 in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study
- (2011) Maryam Fouladi et al. JOURNAL OF CLINICAL ONCOLOGY
- Endothelial FAK as a therapeutic target in disease
- (2011) Giovanni A. Infusino et al. MICROVASCULAR RESEARCH
- Focal adhesion kinase inhibitors are potent anti-angiogenic agents
- (2011) Miguel A. Cabrita et al. Molecular Oncology
- Hypoxia and Inflammation
- (2011) Holger K. Eltzschig et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutralization of the γ-secretase activity by monoclonal antibody against extracellular domain of nicastrin
- (2011) I Hayashi et al. ONCOGENE
- NKX2-3 Transcriptional Regulation of Endothelin-1 and VEGF Signaling in Human Intestinal Microvascular Endothelial Cells
- (2011) Wei Yu et al. PLoS One
- Interleukin 18 induces angiogenesis in vitro and in vivo via Src and Jnk kinases
- (2010) M. A. Amin et al. ANNALS OF THE RHEUMATIC DISEASES
- Synovial tissue hypoxia and inflammation in vivo
- (2010) C. T. Ng et al. ANNALS OF THE RHEUMATIC DISEASES
- ADAM15 regulates endothelial permeability and neutrophil migration via Src/ERK1/2 signalling
- (2010) C. Sun et al. CARDIOVASCULAR RESEARCH
- Angiogenesis and vasculogenesis in rheumatoid arthritis
- (2010) Zoltán Szekanecz et al. CURRENT OPINION IN RHEUMATOLOGY
- The Axis of Thrombospondin-1, Transforming Growth Factor Beta and Connective Tissue Growth Factor: An Emerging Therapeutic Target in Rheumatoid Arthritis
- (2010) Mario C. Rico et al. Current Vascular Pharmacology
- Transcription factor Ets-1 in cytokine and chemokine gene regulation
- (2010) Lisa Russell et al. CYTOKINE
- Endothelial FAK is required for tumour angiogenesis
- (2010) Bernardo Tavora et al. EMBO Molecular Medicine
- A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease
- (2010) I. Dotan et al. GUT
- Junctional Adhesion Molecule-C Is a Soluble Mediator of Angiogenesis
- (2010) B. J. Rabquer et al. JOURNAL OF IMMUNOLOGY
- Mechanical Signals Activate Vascular Endothelial Growth Factor Receptor-2 To Upregulate Endothelial Cell Proliferation during Inflammation
- (2010) J. Liu et al. JOURNAL OF IMMUNOLOGY
- Sphingosine-1-phosphate: a potential therapeutic target for rheumatoid arthritis
- (2010) Peng-fei Hu et al. MOLECULAR BIOLOGY REPORTS
- MEK Inhibitor PD0325901 Significantly Reduces the Growth of Papillary Thyroid Carcinoma Cells In vitro and In vivo
- (2010) Y. C. Henderson et al. MOLECULAR CANCER THERAPEUTICS
- "Go upstream, young man": lessons learned from the p38 saga
- (2009) D Hammaker et al. ANNALS OF THE RHEUMATIC DISEASES
- Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis
- (2009) Stanley B. Cohen et al. ARTHRITIS AND RHEUMATISM
- The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease
- (2009) Franco Scaldaferri et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Targeting the phosphoinositide 3-kinase pathway in cancer
- (2009) Pixu Liu et al. NATURE REVIEWS DRUG DISCOVERY
- Pazopanib
- (2009) Ronald M. Bukowski et al. NATURE REVIEWS DRUG DISCOVERY
- Immature Blood Vessels in Rheumatoid Synovium Are Selectively Depleted in Response to Anti-TNF Therapy
- (2009) Elena Izquierdo et al. PLoS One
- Cytokine Signaling Modules in Inflammatory Responses
- (2008) John J. O'Shea et al. IMMUNITY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now